QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 1, 2006, 26(5):1334-1342; doi:10.1523/JNEUROSCI.2676-05.2006

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Passini, M. A. Articles by Crystal, R. G. Search for Related Content PubMed PubMed Citation Articles by Passini, M. A. Articles by Crystal, R. G.

 Previous Article  |  Next Article 

Neurobiology of Disease
Intracranial Delivery of CLN2 Reduces Brain Pathology in a Mouse Model of Classical Late Infantile Neuronal Ceroid Lipofuscinosis

Marco A. Passini,¹ James C. Dodge,¹ Jie Bu,¹ Wendy Yang,¹ Qi Zhao,¹ Dolan Sondhi,² Neil R. Hackett,² Stephen M. Kaminsky,² Qinwen Mao,³ Lamya S. Shihabuddin,¹ Seng H. Cheng,¹ David E. Sleat,⁴ Gregory R. Stewart,¹ Beverly L. Davidson,³ Peter Lobel,⁴ and Ronald G. Crystal²

¹Neuroscience, Genzyme Corporation, Framingham, Massachusetts 01701, ²Genetic Medicine, Weill Medical College of Cornell University, New York, New York 10021, ³Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa 52242, and ⁴Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical College, Piscataway, New Jersey 08854

Correspondence should be addressed to Marco A. Passini, Genzyme Corporation, One Mountain Road, Framingham, MA 01701-9322. Email: marco.passini{at}genzyme.com

Classical late infantile neuronal ceroid lipofuscinosis (cLINCL) is a lysosomal storage disorder caused by mutations in CLN2, which encodes lysosomal tripeptidyl peptidase I (TPP1). Lack of TPP1 results in accumulation of autofluorescent storage material and curvilinear bodies in cells throughout the CNS, leading to progressive neurodegeneration and death typically in childhood. In this study, we injected adeno-associated virus (AAV) vectors containing the human CLN2 cDNA into the brains of CLN2^–/– mice to determine therapeutic efficacy. AAV2_CUhCLN2 or AAV5_CUhCLN2 were stereotaxically injected into the motor cortex, thalamus, and cerebellum of both hemispheres at 6 weeks of age, and mice were then killed at 13 weeks after injection. Mice treated with AAV2_CUhCLN2 and AAV5_CUhCLN2 contained TPP1 activity at each injection tract that was equivalent to 0.5- and 2-fold that of CLN2^+/+ control mice, respectively. Lysosome-associated membrane protein 1 immunostaining and confocal microscopy showed intracellular targeting of TPP1 to the lysosomal compartment. Compared with control animals, there was a marked reduction of autofluorescent storage in the AAV2_CUhCLN2 and AAV5_CUhCLN2 injected brain regions, as well as adjacent regions, including the striatum and hippocampus. Analysis by electron microscopy confirmed a significant decrease in pathological curvilinear bodies in cells. This study demonstrates that AAV-mediated TPP1 enzyme replacement corrects the hallmark cellular pathologies of cLINCL in the mouse model and raises the possibility of using AAV gene therapy to treat cLINCL patients.

Key words: AAV; LINCL; neurodegeneration; TPP1; Batten; lysosomal storage disease

---

Received June 29, 2005; revised Dec. 2, 2005; accepted Dec. 5, 2005.

Correspondence should be addressed to Marco A. Passini, Genzyme Corporation, One Mountain Road, Framingham, MA 01701-9322. Email: marco.passini{at}genzyme.com

This article has been cited by other articles:

				M. A. Passini, J. Bu, J. A. Fidler, R. J. Ziegler, J. W. Foley, J. C. Dodge, W. W. Yang, J. Clarke, T. V. Taksir, D. A. Griffiths, et al. Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse PNAS, May 29, 2007; 104(22): 9505 - 9510. [Abstract] [Full Text] [PDF]

				E. Siintola, S. Partanen, P. Stromme, A. Haapanen, M. Haltia, J. Maehlen, A.-E. Lehesjoki, and J. Tyynela Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis Brain, June 1, 2006; 129(6): 1438 - 1445. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help